This result, together with the observation that expressing activated Braf in mouse melanocytes primarily generates nevi, has led to the view that MAP kinase pathway activation (through mutation of Braf or, alternatively, Nras) is necessary to initiate melanoma but generally not sufficient. This evidence concerns the gene BRAF and melanoma.